NOV120101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NOV120101, covering 2015-08-14 to 2015-08-14. Get the full timeline:
Most recent: Clinical Trial Update: NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors [Phase 2]